Anlon Healthcare Share price

AHCL

Healthcare Small Cap

13.3

0.13 (-0.97%)

NSE

BSE

Last updated on 30 Apr, 2026 | 15:47 IST

BUYSELL

Today's High

13.53

Today's Low

13.01

52 Week Low

9.08

52 Week High

17.28

Free Demat with Zero AMC*

Anlon Healthcare Chart

ChartIQ

TradingView

Anlon Healthcare Share Key Metrics

Volume

28.70 L

Market Cap

706.91 CR

LTQ@LTP

305@13.30

ATP

13.26 Var Margin

20.02 %

Circuit Range

10.75-16.11

Delivery %

45.96 %

Value

3.81 CR

ASM/GSM

No

Market Lot

1

Summary

Anlon Healthcare share price stands at ₹13.3 at 30 Apr, 2026 | 15:47. The stock Anlon Healthcare intraday movement has stayed between ₹13.01 and ₹13.53, while on a 52-week basis it has fluctuated from ₹9.08 to ₹17.28.

In terms of trading activity, Anlon Healthcare has recorded a volume of 2869855 shares. The Anlon Healthcare has a market cap of ₹531515000. The stock’s Average Traded Price (ATP) stands at ₹1326, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 305, 1330.

The Anlon Healthcare operates within a circuit range of ₹10.75-16.11 – ₹10.75-16.11, with a Value of ₹3.81 CR. The Delivery Percentage for the day is 45.96%. Additionally, Anlon Healthcare currently falls under the No framework, and trades with a market lot size of 1.

Anlon Healthcare Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

64.93

Sector P/B

3.52

Sec. Div. Yield

0.57

Anlon Healthcare Resistance and Support

Pivot 13.64

Resistance

First Resistance

14.08

Second Resistance

14.72

Third Resistance

15.16

Support

First Support

13

Second Support

12.56

Third Support

11.92

Anlon Healthcare Shareholding Pattern

2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

52.68%

Mutual Fund

0%

Insurance

0.06%

Foreign Institutional Investors

0.32%

Domestic Institutional Investors

4.54%

Retail

42.4%

Others

0%

Total Promoters

MAR '26

52.68%

Anlon Healthcare Corporate Actions

Date	Agenda
2026-03-06	Bonus issue & Stock Split
2026-02-09	Quarterly Results
2025-09-27	Others

Anlon Healthcare News

Bonus issue & stock split: Last day to buy shares of this smallcap company before record date. Do you own?

Anlon Healthcare is undertaking a bonus issue and stock split, with today marking the last day for investors to purchase shares to be eligible for these corporate actions before the record date.

Apr 23 2026 07:04:00

Anlon Healthcare Ltd - 544497 - Intimation Of New ISIN

Anlon Healthcare's new ISIN INE0Y8W01025 activated for equity shares following a 1:5 stock split. The face value has changed from ₹10 to ₹2 per share, with the sub-division effective from the record date of April 24, 2026.

Apr 22 2026 16:04:00

Anlon Healthcare Limited

Anlon Healthcare completed a 1:5 stock split, dividing shares from ₹10 face value to ₹2 face value, effective April 24, 2026. The new ISIN INE0Y8W01025 has been activated by depositories.

Apr 22 2026 16:04:00

Anlon Healthcare Ltd - 544497 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

Anlon Healthcare acquired a 63.98% stake in Remember India Health Links Private Limited for ₹5.38 crore in cash. This strategic move aims to transform Anlon from an API manufacturer to a full-service pharmaceutical provider, expanding into finished dosage formulations.

Apr 16 2026 14:04:00

Anlon Healthcare Limited

Anlon Healthcare acquired 63.98% stake in Remember India Health Links Private Limited for ₹5.38 crore. This acquisition transforms Anlon from an API manufacturer to a comprehensive pharmaceutical provider.

Apr 16 2026 14:04:00

Anlon Healthcare Ltd - 544497 - Announcement under Regulation 30 (LODR)-Credit Rating

Brickwork Ratings withdrew credit ratings for Anlon Healthcare's ₹24.50 crore bank loan facilities and ₹10.36 crore term loans. The withdrawal follows the closure of the facility and an upgrade by Brickwork Ratings.

Apr 15 2026 16:04:00

Anlon Healthcare Ltd - 544497 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Anlon Healthcare announced the record date for its stock split and bonus share issue. This disclosure was made via newspaper publication in Financial Express editions on April 10, 2026.

Apr 10 2026 12:04:00

Anlon Healthcare Ltd - 544497 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

Anlon Healthcare shareholders approved a 1:5 stock split, reducing the equity share face value from ₹10 to ₹2. Additionally, the authorized share capital was increased from ₹55 crores to ₹110 crores, with both actions passed via postal ballot on April 8, 2026.

Apr 09 2026 18:04:00

Anlon Healthcare Limited

Anlon Healthcare shareholders approved a 1:5 stock split via postal ballot on April 08, 2026, reducing face value from ₹10 to ₹2 per share. This also doubled the authorized share capital to ₹110 crore from ₹55 crore, to facilitate future capital needs.

Apr 09 2026 18:04:00

Anlon Healthcare Ltd - 544497 - Corporate Action-Board recommends Bonus Issue

Anlon Healthcare fixed April 24, 2026, as the record date for corporate actions. This includes a 1:5 stock split, changing face value from ₹10 to ₹2, and a 1:1 bonus share issue.

Apr 09 2026 15:04:00

NSE : 758968

BSE : 544497

ISIN : INE0Y8W01025

Our Company was originally incorporated as 'Anlon Ventures Private Limited' a private limited company under the erstwhile Companies Act 1956 pursuant to a certificate of incorporation dated November 19 2013 issued by the RoC. The name of our Company was changed from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh certificate of incorporation dated May 27 2015 was issued by the RoC pursuant to the approval of the Board on May 1 2015 and the Shareholders on May 5 2015. Our Company was subsequently converted to a public limited company and the name of our Company was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited' pursruant to the approval of the Board dated July 8 2024 and Shareholders August 3 2024 and a fresh certificate of incorporation dated September 2 2024 was issued by the RoC.Our Company was incorporated in the year 2013 as 'Anlon Ventures Private Limited'. In the year 2015 our Company changed its name to Anlon Healthcare Private Limited and decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs. Following this decision our company began the process of land procurement construction and installation of plant and machinery which were completed in the year 2017. Year 2017 onwards we started our trial production of pharma intermediates and APIs.Major Events and Milestones:2013- Incorporated as 'Anlon Ventures Private Limited'2015- Change of name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.2017- Received ISO 9001:2015 certification2018- Commenced commercial Production of Pharma Intermediate and API2018- Made our first export of our product to South Korea2019- Received Good Manufacturing Practice certification for our Manufacturing Facility- Received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency Japan2021- Received Good Manufacturing Practice – World Health Organization Certification for our Manufacturing Facility2024- Received approval for Drug Master File from Brazilian Health Regulatory Agency for our API product namely loxoprofen sodium dihydrate- Conversion of our Company from private limited to public limited and the consequent change of name from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.

Name	Position
Punitkumar R Rasadia	Chairman & Managing Director
Meet Atulkumar Vachhani	Whole Time Director

Anlon Healthcare Similar Stocks

Anlon Healthcare FAQs

The Buying Price of Anlon Healthcare share is 13.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Anlon Healthcare stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Anlon Healthcare, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Anlon Healthcare shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Anlon Healthcare shares is 0. Useful to assess the stock's value relative to its book value.

To assess Anlon Healthcare’s valuation compare Sector P/E, P/B which are 64.93 & 3.52 with sector averages, along with growth rates and financial metrics.

The Market Cap of Anlon Healthcare is 706.91 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Anlon Healthcare share price is 17.28 & 9.08. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Anlon Healthcare belongs to the Healthcare sector.